The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer
Volker Fendrich, Nai Ming Chen, Meike Neef, Jens Waldmann, Malte Buchholz, Georg Feldmann, Emily P. Slater, Anirban Maitra, Detlef K. Bartsch
Dive into the research topics of 'The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer'. Together they form a unique fingerprint.